AbCellera Biologics Inc Sustainability Reports
AbCellera Biologics Inc. discovers and develops antibody therapeutics using an AI-powered, high-throughput screening technology platform. The company researches natural immune systems to isolate high-quality antibody candidates for its clinical pipeline and strategic partners.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
LEI: 9845000861BC95FF9F73
FIGI: BBG00LLW2MH0
3 reports from 2021 to 2024
